The invention provides 24-hydroxyvitamin D compounds and methods for their
use in the treatment and prophylaxis of hyperparathyroidism and
hyperproliferative diseases, and in the modulation of the immune and
inflammatory responses as well as the treatment of bone depletive
disorders.